Women given the statin, pravastatin (Pravachol), had 12-times as much breast cancer as women given a placebo in the CARE trial.

Drug companies and their paid researchers have tried to convince people that statins lower the risk of cancer, but this study and many others suggest that the exact opposite is true — that statins increase the risk of cancer, not decrease the risk.

Long-term statin use (10 years or more) is associated with a more than 2-fold increased risk of breast cancer according to researchers at the Fred Hutchinson Cancer Research Center in Seattle, Washington.

Drug companies 
and their paid researchers have tried to convince people that 
statins lower the risk of cancer,
 but this study 
and many others 
suggest that the 
exact opposite is true — 
that statins increase the risk of cancer, not decrease the risk.

Proton pump inhibitors (PPI’s) increase the risk of major depression according to a study from Taiwan.

People taking 31-120 doses per year were 10% more likely (1.1 times more likely) to have major depression than non-users.

(This difference did not quite reach statistical significance, but was very close—close enough for me.)

People taking 121-365 doses per year were 61% more likely (1.6 times more likely) to have major depression than non-users.

People taking more than 365 doses per year were 108% more likely (2.1 times more likely) to have major depression than non-users.

The risk of subsequent major depression after starting various PPI’s is shown below.

Patients 75 years and older taking a proton pump inhibitor (PPI) were 38% more likely to have any type of dementia and 44% more likely to have Alzheimer’s than non-users according to a study from Germany.

People who consumed seven (7) servings of fruits and vegetables per day were 33% less likely to die over the next 7.7 years than people eating less than one (1) serving per day according to a study from England.

This protective effect rose to 42% after excluding deaths that occurred during the first year.

“A robust inverse association exists between fruit and vegetable consumption and mortality, with benefits seen in up to 7+ portions daily,” the authors of the study concluded.

People who consumed 2-3 servings of vegetables per day were 19% less likely to die over the next 7.7 years than people eating less than one (1) serving per day according to a study from England.

People who consumed 2-3 servings of fruit per day were 10% less likely to die over the next 7.7 years than people eating less than one (1) serving per day according to a study from England.

People who consumed nuts (less than one serving per week) versus people who did not consume nuts were 11% less likely to die over a median follow-up of 7 years according to a study from Iran.

They studied a group of people where nut consumption does not track with a healthy lifestyle.

People who consumed one to less than three (1-3) servings of nuts per week were 25% less likely to die over a median follow-up of 7 years than people who did not consume nuts according to a study from Iran.

They studied a group of people where nut consumption does not track with a healthy lifestyle.

People who consumed three or more servings of nuts per week were 29% less likely to die over a median follow-up of 7 years than people who did not consume nuts according to a study from Iran.

They studied a group of people where nut consumption does not track with a healthy lifestyle.

People who consumed artificially-sweetened beverages were 3-times more likely to have an ischemic stroke over the next ten (10) years compare to people who drank no artificially-sweetened beverages according to a study which followed 2888 people age greater than 45 years

People who consumed artificially-sweetened beverages were 2.9-times more likely to be diagnosed with Alzheimer’s disease over the next ten (10) years compare to people who drank no artificially-sweetened beverages according to a study which followed 2888 people aged 45 years and older.

Men whose total cholesterol levels were less than 160 mg/dL were 60% MORE likely to die during the next 5-13 years compared with men whose cholesterol levels were 160-199 mg/dL according to a 2008 meta-analysis of 5 studies in Japan which included a total of more than 173,000 people.

In other words, having LOW cholesterol levels was associated with a dramatically HIGHER risk of death.

Based on this data, do you think that it is a mistake to try and lower your cholesterol levels as low as possible as recommended by the “experts”?

Yes, of course it is!

It is a big mistake!

Men whose total cholesterol levels were 200-239 mg/dL were 18% LESS likely to die during the next 5-13 years compared with men whose cholesterol levels were 160-199 mg/dL according to a 2008 meta-analysis of 5 studies in Japan which included a total of more than 173,000 people.

In other words, having HIGHER cholesterol levels was associated with a LOWER risk of death.

Or to say this in reverse, having HIGHER cholesterol levels was associated with a LOWER risk of death.

Why would I want to lower my cholesterol levels?

I don’t!

Men whose total cholesterol levels were 240 mg/dL or greater were 24% LESS likely to die during the next 5-13 years compared with men whose cholesterol levels were 160-199 mg/dL according to a 2008 meta-analysis of 5 studies in Japan which included a total of more than 173,000 people.

In other words, having HIGHER cholesterol levels was associated with a LOWER risk of death.

Or to say this in reverse, having HIGHER cholesterol levels was associated with a LOWER risk of death.

Why would I want to lower my cholesterol levels?

I don’t!

Women whose total cholesterol levels were less than 160 mg/dL were 41% MORE likely to die during the next 5-13 years compared with women whose cholesterol levels were 160-199 mg/dL according to a 2008 meta-analysis of 5 studies in Japan which included a total of more than 173,000 people.

Data from this meta-analysis suggests that elevated cholesterol levels do NOT increase a woman’s risk of death, but if cholesterol levels are LOW — below 160 mg/dL — there is a dramatic (41%) INCREASED risk of death.

Should a woman try to lower her cholesterol levels?

No, I don’t think so!

Women whose total cholesterol levels were 200-239 mg/dL were NO MORE likely to die during the next 5-13 years compared with women whose cholesterol levels were 160-199 mg/dL according to a 2008 meta-analysis of 5 studies in Japan which included a total of more than 173,000 people.

Data from this meta-analysis suggests that elevated cholesterol levels do NOT increase a woman’s risk of death, but if cholesterol levels are LOW — below 160 mg/dL — there is a dramatic (41%) INCREASED risk of death.

Should a woman try to lower her cholesterol levels?

No, I don’t think so!

Women whose total cholesterol levels were 240 mg/dL or GREATER were NO MORE likely to die during the next 5-13 years compared with women whose cholesterol levels were 160-199 mg/dL according to a 2008 meta-analysis of 5 studies in Japan.

Data from this meta-analysis suggests that elevated cholesterol levels do NOT increase a woman’s risk of death, but if cholesterol levels are LOW — below 160 mg/dL — there is a dramatic (41%) INCREASED risk of death.

Should a woman try to lower her cholesterol levels?

No, I don’t think so!

The one-fourth of women 
consuming the most coffee were 
7% less likely to die 
during an average follow-up of 16.4 years 
compared to non-consumers 
according to a study looking at 
14,800 people in 10 European countries.

The one-fourth of men 
consuming the most coffee were 
12% less likely to die 
during an average follow-up of 16.4 years 
compared to non-consumers 
according to a study looking at 
14,800 people in 10 European countries.

In the first statin study called the Expanded Clinical Evaluation of Lovastatin (EXCEL) study (1991), all-cause mortality was 2.8 times greater in people given lovastatin than those given a placebo (0.50% vs 0.18%) during the first year of follow-up as noted in a 1992 paper published in the British Medical Journal titled Should there be a moratorium on the use of cholesterol lowering drugs?

Statin use among US adults increased by 68% from 1999 to 2005, from 8% of people surveyed to 13.4% of people surveyed.

How much do you think this reduced heart attacks, strokes and coronary heart disease?

Would you be surprised to learn that during this time that:

• Heart attacks increased by 16%!
  (from 3.4% to 3.7%)
• Strokes increased by 45%!
  (from 2.0% to 2.9%)
• Coronary heart disease increased by 32%!
  (from 2.8% to 3.7%)
• Type 2 diabetes increased by 32%!
  (from 7.8% to 10.3%)
• People with one or more of these conditions increased by 19%!
  (from 13.4% to 16%)

Do you believe that statins reduce the risk of heart attack, stroke and death?

I do not.

The results of the study mentioned above suggests the exact opposite.

You might think that fasting to lose weight would cause a drop in metabolism—I certainly assumed that it would—but this is not true according to a new, very interesting book called The Complete Guide to Fasting: Heal Your Body Through Intermittent, Alternate-Day, and Extended Fasting by Jason Fung, MD and Jimmie Moore.

Fasting does not reduce basal metabolism.

In fact, one study suggests that the exact opposite happens.

4 days of continuous fasting increased metabolism by 12%

They noted that one study found that four (4) days of continuous fasting increased basal metabolism by 12 percent.

Dr. Fung explains why this is.

Does fasting to lose weight causes you to lose muscle?

No, it does not according to a new book called The Complete Guide to Fasting: Heal Your Body Through Intermittent, Alternate-Day, and Extended Fasting by Jason Fung, MD and Jimmie Moore.

“Alternate-day fasting over seventy days decreased body weight by 6 percent, but fat mass decreased by 11.4 percent and lean mass (muscle and bone) did not change at all,” Dr. Fung writes.

“The normal protein breakdown of around seventy-five [75] grams per day falls to fifteen to twenty [15-20] grams per day during fasting.

“Much of the amino acids that are broken down during regular turnover of cells are reabsorbed into new proteins.”

Does fasting to lose weight cause low blood sugar?

No, it does not according to a new book called The Complete Guide to Fasting: Heal Your Body Through Intermittent, Alternate-Day, and Extended Fasting by Jason Fung, MD and Jimmie Moore.

“Sometimes people worry that blood sugar will fall very low during fasting and they will become shaky and sweaty. Luckily, this does not actually happen,” Dr. Fung writes.

If someone fasts for a day, will they eat twice as much the next day?

No according to a new book called The Complete Guide to Fasting: Heal Your Body Through Intermittent, Alternate-Day, and Extended Fasting by Jason Fung, MD and Jimmie Moore.

Studies show that people eat roughly an extra 500 calories on the day after a fast, but not nearly enough to make up for the calories lost on the day where people consume no calories Dr. Fung notes.

High levels of leisure-time physical activity were associated with a lower risk of 13 types of cancer when compared to people with low levels of leisure-time physical activity according to a study done by researchers at the U.S. National Cancer Institute.

The 13 cancers associated with a lower risk were:

• 10% lower risk of breast cancer
• 13% lower risk of bladder cancer
• 13% lower risk of rectal cancer
• 15% lower risk of head and neck cancer
• 16% lower risk of colon cancer
• 17% lower risk of multiple myeloma
• 20% lower risk of myeloid leukemia
• 21% lower risk of endometrial cancer
• 22% lower risk of gastric cardia
• 23% lower risk of kidney cancer
• 26% lower risk of lung cancer
• 27% lower risk of liver cancer
• 42% lower risk of esophageal cancer

As sugar intake increases, the risk of dying from cardiovascular disease (heart attack or stroke) increases according to a recent analysis by researchers at the U.S. Centers for Disease Control and Prevention.

During an average follow-up of 14.6 years, compared to the one-fifth of people consuming the least amount of added sugar:

• the one-fifth consuming the next most amount of sugar were 7% more likely to die from cardiovascular disease
• the one-fifth consuming the third highest amount of sugar were 18% more likely to die from cardiovascular disease
• the one-fifth consuming the second highest amount of sugar were 38% more likely to die from cardiovascular disease
• the one-fifth consuming the most amount of sugar were 103% more likely to die from cardiovascular disease (2X as likely to die from CVD)

This was after adjusting for age, sex, race/ethnicity as well as sociodemographic, behavioral, and clinical characteristics.

A daily dose of 3,000 mg of L-carnitine per day given to people who had suffered a heart attack resulted in a 52% lower risk of all-cause mortality over some number of months according to a meta-analysis of five (5) studies that included 3108 people.

The one-third of males with the highest lead levels as measured in the kneecap (bone lead levels as opposed to blood lead levels) compared to the one-third with the lowest lead levels were 25% more likely to die from any cause during an average follow-up of 8.9 years according to the Veterans Affairs Normative Aging Study.

Blood lead levels were not associated with an increased risk of death, only bone lead levels were.

“We found bone lead to be associated with all-cause and cardiovascular mortality in an environmentally exposed population with low blood lead levels,” the authors of the paper concluded.

“This study suggests that cumulative lead exposure from prior decades of high environmental exposures continues to significantly affect risk of death despite recent declines in environmental lead exposure.”

The one-third of males with the highest lead levels as measured in the kneecap (bone lead levels as opposed to blood lead levels) compared to the one-third with the lowest lead levels were 42% more likely to die from cardiovascular death during an average follow-up of 8.9 years according to the Veterans Affairs Normative Aging Study.

The one-third of males with the highest lead levels as measured in the kneecap (bone lead levels as opposed to blood lead levels) compared to the one-third with the lowest lead levels were 87% more likely to die from ischemic heart disease (reduced blood supply to the heart) during an average follow-up of 8.9 years according to the Veterans Affairs Normative Aging Study.

Men with the highest one-third hair mercury content—2 mcg of mercury per gram of hair or higher—were 38% more likely to die during an average follow-up of 13.9 years compared with men in the lower two-thirds according to a study from Finland which followed 1871 Finnish men aged 42 to 60 years free of previous coronary heart disease or stroke at baseline.

Men with the highest one-third hair mercury content—2 mcg of mercury per gram of hair or higher—were 56% more likely to develop coronary heart disease, 68% more likely to develop cardiovascular disease (heart attack or stroke), and 60% more likely to have an acute coronary event during an average follow-up of 13.9 years compared with men in the lower two-thirds according to a study from Finland which followed 1871 Finnish men aged 42 to 60 years free of previous coronary heart disease or stroke at baseline.

The one-fifth of men with the highest toenail mercury levels were 2.2 times more likely to have a heart attack compared to the one-fifth of men with the lowest levels according to a study which looked at 684 men from eight (8) European countries and Israel who had a heart attack and compared them to 724 men selected to be representative of the same populations.

People who had a prior heart attack who were given 40 infusions of EDTA chelation therapy compared to those given a placebo were 18% less likely to die from any cause, have a heart attack, have a stroke, have coronary revascularization, or hospitalization for angina over the next 5 years.

A subset of people who were Type 2 diabetics had a 41% lower risk of these events happening.

EDTA chelation helps to remove heavy metals such as lead and cadmium.

“[A] body of epidemiological data showing that accumulation of biologically active metals, such as lead and cadmium, is an important risk factor for cardiovascular disease,” the authors of the paper note.

Type 2 diabetics with a prior heart attack who were given 40 infusions of EDTA chelation therapy compared to those given a placebo had a

• 43 percent reduction in death from any cause over 1-5 years
• 41 percent overall reduction in the risk of any cardiovascular event over 1-5 years
• 40 percent reduction in the risk of death from heart disease, nonfatal stroke, or nonfatal heart attack during a 1-5 year follow-up
• 52 percent reduction in recurrent heart attacks over 1-5 years

according to a study called the Trial to Assess Chelation Therapy (TACT) that was sponsored by the National Center for Complementary and Integrative Health and the National Heart, Lung, and Blood Institute at the U.S. National Institutes of Health which was the first large-scale, multicenter clinical trial on chelation therapy in people who have had heart attacks.

EDTA chelation only benefited diabetics

EDTA chelation only benefited diabetics; it did not benefit non-diabetics.

Niacin lowers the risk of a major coronary event (heart attack, death from heart attack or coronary bypass surgery) by an average of 25% according to a meta-analysis of eleven (11) studies which involved a total of 6545 people.

Niacin lowers the risk of a stroke by an average of 26% according to a meta-analysis of eleven (11) studies which involved a total of 6545 people.

Niacin raises HDL cholesterol levels by an average of 20% notes a paper on niacin.